E-LIB Suche - Ergebnisse für: Levra, Matteo Giaj

1

Altered splicing of ATG16‐L1 mediates acquired resistance t..:

Hatat, Anne‐Sophie ; Benoit‐Pilven, Clara ; Pucciarelli, Amélie...
Molecular Oncology. 16 (2022) 19 - p. 3490-3508 , 2022

Link: https://doi.org/10.1002/..

2

Survival of clinical stage III NSCLC according to therapeut..:

Benet, Justin ; Toffart, Anne-Claire ; Brichon, Pierre-Yves...
Cancer Treatment and Research Communications. 30 (2022) - p. 100508 , 2022

Link: https://doi.org/10.1016/..

3

Factors associated with survival of patients with solid Can..:

Gheerbrant, Hubert ; Timsit, Jean-François ; Terzi, Nicolas...
BMC Cancer. 21 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

4

Discontinuation of immune checkpoint inhibitor (ICI) above ..:

Bilger, Geoffroy ; Girard, Nicolas ; Doubre, Hélène...
Cancer Immunology, Immunotherapy. , 2021

Link: https://doi.org/10.1007/..

5

Immune Checkpoint Inhibitors Rechallenge Efficacy in Non–Sm..:

Gobbini, Elisa ; Toffart, Anne Claire ; Pérol, Maurice...
Clinical Lung Cancer. 21 (2020) 5 - p. e497-e510 , 2020

Link: https://doi.org/10.1016/..

6

Nivolumab treatment in advanced non-small cell lung cancer:..:

Assié, Jean-Baptiste ; Corre, Romain ; Levra, Matteo Giaj...
Therapeutic Advances in Medical Oncology. 12 (2020) - p. 175883592096723 , 2020

Link: https://doi.org/10.1177/..

7

Trends in response rate and survival in small-cell lung can..:

Lattuca-Truc, Mickaël ; Timsit, Jean-François ; Levra, Matteo Giaj...
Lung Cancer. 131 (2019) - p. 122-127 , 2019

Link: https://doi.org/10.1016/..

8

P1.07-012 Efficacy of Immune Checkpoint Inhibitors in Large..:

Levra, Matteo Giaj ; Mazieres, Julien ; Valette, Clarisse Audigier...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S702-S703 , 2017

Link: https://doi.org/10.1016/..

9

P1.06-005 An International Cohort of Patients with Small Ce..:

Levra, Matteo Giaj ; Novello, Silvia ; Ferrer, Leonie...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S667 , 2017

Link: https://doi.org/10.1016/..

10

Clinical meta-analyses of targeted therapies in adenocarcin..:

Bria, Emilio ; Bonomi, Maria ; Pilotto, Sara...
Targeted Oncology. 8 (2013) 1 - p. 35-45 , 2013

Link: https://doi.org/10.1007/..

11

Early Response to Chemotherapy in Patients With Non–Small-C..:

Novello, Silvia ; Vavalà, Tiziana ; Levra, Matteo Giaj...
Clinical Lung Cancer. 14 (2013) 3 - p. 230-237 , 2013

Link: https://doi.org/10.1016/..

12

Comparison of doxorubicin and weekly paclitaxel efficacy in..:

Italiano, Antoine ; Cioffi, Angela ; Penel, Nicolas...
Cancer. 118 (2011) 13 - p. 3330-3336 , 2011

Link: https://doi.org/10.1002/..

13

Malignant pleural mesothelioma: clinicopathologic and survi..:

Borasio, Piero ; Berruti, Alfredo ; Billé, Andrea...
European Journal of Cardio-Thoracic Surgery. 33 (2008) 2 - p. 307-313 , 2008

Link: https://doi.org/10.1016/..

14

Lung cancer, comorbidities, and medication: the infernal tr..:

Pluchart, Hélène ; Chanoine, Sébastien ; Moro-Sibilot, Denis...
Frontiers in Pharmacology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

15

Immune Checkpoint Inhibitors in Patients With Cancer and In..:

Tagliamento, Marco ; Remon, Jordi ; Giaj Levra, Matteo...
JTO Clinical and Research Reports. 4 (2023) 1 - p. 100446 , 2023

Link: https://doi.org/10.1016/..